Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 11 Member and Observer Countries with diverse trial support services
and contribute to other capacity building projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial



The EFGCP Annual Conference 2019 focuses on achieving better integration of clinical research in healthcare.

Many scientific, methodological and regulatory challenges in research and development of treatments for different diseases have been successfully overcome in the past years. However, in order to reach the ultimate ethical objective of ensuring patient centricity in treatment development, changes must be envisaged in our healthcare environment, in clinical research concepts, in the digital environment, in the way stakeholders collaborate, in the healthcare professionals’ knowledge and attitude towards new treatments development, in the requirements of competent authorities and payers, and in funding strategies. 

Conference sessions will include:

•    Clinical trials and novel Research & Development strategies
•    Patient-driven initiatives for a roadmap to health
•    The need for different protocol designs and concepts
•    The optimal use of other available data sources

For more information, visit the EFGCP website


SY-Stem, a symposium focusing on the next generation of stem cell researchers, is an annual meeting in Vienna. It is jointly organised by the Research Institute of Molecular Pathology (IMP) and the Institute of Molecular Biotechnology (IMBA).

During the event, recognised keynote speakers as well as aspiring young group leaders will discuss the latest advances in stem cell biology in an informal and collaborative setting. 

The 2019 sessions include the following topics:

  • Adult stem cells
  • Germ lines & totipotency
  • Organoids
  • Pluripotency, differentiation & reprogramming
  • Regeneration & ageing

For more information, click here


The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on “In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals. 

This workshop is aimed to present the following topics: 

  1. Kinetics of vaccines distribution and persistence
  2. Pathogen penetration and dissemination
  3. Host response to vaccines and pathogens exposure

The workshop will be focused on implication of these approaches for pre-clinical research and translational medicine. International experts of diverse expertise on fluorescent based technologies as well as whole body Positron Emission Tomography–Computed Tomography (PET-CT) and Magnetic Resonance Imaging (MRI) technologies will be invited to describe and comment the application of these tools for vaccine research and development.

Four thematic sessions will be offered:

  1. In vivo imaging of host response: Visualizing host cells in living animals
  2. Dynamics of pathogen and vaccine antigen distribution and/or dissemination: Local interactions and micro-environment 
  3. Whole body imaging of host/pathogen & antigen interactions
  4. Transfer to clinical investigation and practice

Roundtables will be held to discuss the needs and opportunities for imaging in vaccine development. 

Registration is free and compulsory until 1 March 2019.

For more information, please contact Isabelle Mangeot (isabelle.mangeot@cea.fr)
Due to the fact that there are limited places available and participation will be on a “first come first served basis”, registration will close when maximum number of participants will be reached.

Find all information and the preliminary program on the TRANSVAC2 website and IDMIT website.

(ECRIN is leading the work package on clinical trial support in the TRANSVAC2 project.)